A Belgian multicenter phase II randomized trial in HER2-negative metastatic breast cancer evaluating consolidation antiangiogenic therapy with sunitinib after objective response to taxane-based chemotherapy

Hans Wildiers, Christel Fontaine, Peter Vuylsteke, M. Martens, J-L Canon, W. Wynendaele, C. Focan, Jacques De Greve, P. Squifflet, Robert Paridaens

Research output: Contribution to journalArticle

Abstract

No abstract available
Original languageEnglish
Pages (from-to)190-190
Number of pages1
JournalEuropean Journal of Cancer. Supplement
Volume8
Issue numberMarch
Publication statusPublished - 2010

Keywords

  • breast cancer
  • taxane
  • chemotherapy

Fingerprint Dive into the research topics of 'A Belgian multicenter phase II randomized trial in HER2-negative metastatic breast cancer evaluating consolidation antiangiogenic therapy with sunitinib after objective response to taxane-based chemotherapy'. Together they form a unique fingerprint.

Cite this